Literature DB >> 19084502

Estrogen and hypoxia regulate estrogen receptor alpha in a synergistic manner.

Jinhyung Michael Yi1, Hyeok Yi Kwon, Jung Yoon Cho, Young Joo Lee.   

Abstract

Hypoxia activates and degrades estrogen receptor alpha (ERalpha) in human breast cancer cells, which may play an important role in the development and progression of breast cancer. In this study, the synergistic effects of estrogen (E(2)) and hypoxia on ERalpha-mediated transactivation and ERalpha degradation were investigated. ERalpha-mediated transcriptional activity was synergistically increased by E(2) and hypoxia, as determined by the transient expression of ERalpha and ER-responsive reporter plasmids in HEK 293 cells. Twenty hours of E(2) and hypoxia treatment synergistically induced degradation of ERalpha by 95% via a proteasome-dependent pathway in MCF-7 cells. These results provide evidence that hypoxia may stimulate yet unknown factor(s), which can further stimulate ERalpha signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19084502     DOI: 10.1016/j.bbrc.2008.11.142

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth.

Authors:  Jun Yang; Adrian M Jubb; Luke Pike; Francesca M Buffa; Helen Turley; Dilair Baban; Russell Leek; Kevin C Gatter; Jiannis Ragoussis; Adrian L Harris
Journal:  Cancer Res       Date:  2010-08-03       Impact factor: 12.701

2.  The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1alpha (HIF-1alpha) in breast cancer cells and cardiomyocytes.

Authors:  Anna Grazia Recchia; Ernestina Marianna De Francesco; Adele Vivacqua; Diego Sisci; Maria Luisa Panno; Sebastiano Andò; Marcello Maggiolini
Journal:  J Biol Chem       Date:  2011-01-25       Impact factor: 5.157

Review 3.  Breast tumor and stromal cell responses to TGF-β and hypoxia in matrix deposition.

Authors:  Colleen S Curran; Patricia J Keely
Journal:  Matrix Biol       Date:  2012-12-20       Impact factor: 11.583

4.  Estrogen receptor beta inhibits transcriptional activity of hypoxia inducible factor-1 through the downregulation of arylhydrocarbon receptor nuclear translocator.

Authors:  Wonchung Lim; Yeomyung Park; Jungyoon Cho; Choa Park; Joonwoo Park; Young-Kwon Park; Hyunsung Park; Youngjoo Lee
Journal:  Breast Cancer Res       Date:  2011-03-24       Impact factor: 6.466

5.  The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytes.

Authors:  Rosamaria Lappano; Anna Grazia Recchia; Ernestina Marianna De Francesco; Tommaso Angelone; Maria Carmela Cerra; Didier Picard; Marcello Maggiolini
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

6.  Adipocyte hypoxia promotes epithelial-mesenchymal transition-related gene expression and estrogen receptor-negative phenotype in breast cancer cells.

Authors:  Aiwei Yao-Borengasser; Behjatolah Monzavi-Karbassi; Rebecca A Hedges; Lora J Rogers; Susan A Kadlubar; Thomas Kieber-Emmons
Journal:  Oncol Rep       Date:  2015-03-30       Impact factor: 3.906

7.  Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions.

Authors:  Oihana Iriondo; Miriam Rábano; Giacomo Domenici; Onintza Carlevaris; José Antonio López-Ruiz; Ignacio Zabalza; Edurne Berra; Maria dM Vivanco
Journal:  Oncotarget       Date:  2015-10-13

8.  Estrogen-dependent downregulation of hypoxia-inducible factor (HIF)-2α in invasive breast cancer cells.

Authors:  Jerry H Fuady; Katrin Gutsche; Sara Santambrogio; Zsuzsanna Varga; David Hoogewijs; Roland H Wenger
Journal:  Oncotarget       Date:  2016-05-24

9.  BRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression.

Authors:  M Yan; M Rayoo; E A Takano; H Thorne; S B Fox
Journal:  Br J Cancer       Date:  2009-09-01       Impact factor: 7.640

10.  The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer.

Authors:  Mark A Wade; Dominic Jones; Laura Wilson; Jacqueline Stockley; Kelly Coffey; Craig N Robson; Luke Gaughan
Journal:  Nucleic Acids Res       Date:  2014-12-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.